Page last updated: 2024-09-05

ru 43044 and trimegestone

ru 43044 has been researched along with trimegestone in 1 studies

Compound Research Comparison

Studies
(ru 43044)
Trials
(ru 43044)
Recent Studies (post-2010)
(ru 43044)
Studies
(trimegestone)
Trials
(trimegestone)
Recent Studies (post-2010) (trimegestone)
100152284

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benhamou, B; Gofflo, D; Guillot, B; Moras, D; Ossart, C; Philibert, D; Robin-Jagerschmidt, C; Vergezac, A; Wurtz, JM1

Other Studies

1 other study(ies) available for ru 43044 and trimegestone

ArticleYear
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:7

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Furylfuramide; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mifepristone; Models, Molecular; Molecular Sequence Data; Progestins; Promegestone; Protein Conformation; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Proteins; Sequence Homology, Amino Acid; Substrate Specificity; Transcriptional Activation

2000